4//SEC Filing
Scalzo Richard William 4
Accession 0000950170-25-022455
CIK 0001818794other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 5:09 PM ET
Size
5.6 KB
Accession
0000950170-25-022455
Insider Transaction Report
Form 4
Scalzo Richard William
SVP, Head of Finance & Admin.
Transactions
- Sale
Common Stock
2025-02-18$13.95/sh−2,488$34,708→ 124,590 total
Footnotes (3)
- [F1]Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on November 15, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $13.95 to $14.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.
- [F3]Includes 114,079 unvested RSUs.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
Related Parties
1- filerCIK 0001789545
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 5:09 PM ET
- Size
- 5.6 KB